BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 17729162)

  • 1. Radiosensitization of human glioma cells by cyclooxygenase-2 (COX-2) inhibition: independent on COX-2 expression and dependent on the COX-2 inhibitor and sequence of administration.
    Kuipers GK; Slotman BJ; Wedekind LE; Stoter TR; Berg Jv; Sminia P; Lafleur MV
    Int J Radiat Biol; 2007 Oct; 83(10):677-85. PubMed ID: 17729162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiosensitizing potential of the selective cyclooygenase-2 (COX-2) inhibitor meloxicam on human glioma cells.
    Bijnsdorp IV; van den Berg J; Kuipers GK; Wedekind LE; Slotman BJ; van Rijn J; Lafleur MV; Sminia P
    J Neurooncol; 2007 Oct; 85(1):25-31. PubMed ID: 17447009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro.
    Ohneseit PA; Krebiehl G; Dittmann K; Kehlbach R; Rodemann HP
    Radiother Oncol; 2007 Feb; 82(2):229-38. PubMed ID: 17207548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels.
    Shin YK; Park JS; Kim HS; Jun HJ; Kim GE; Suh CO; Yun YS; Pyo H
    Cancer Res; 2005 Oct; 65(20):9501-9. PubMed ID: 16230415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective cyclooxygenase-2 inhibitors inhibit growth and induce apoptosis of bladder cancer.
    Gee J; Lee IL; Jendiroba D; Fischer SM; Grossman HB; Sabichi AL
    Oncol Rep; 2006 Feb; 15(2):471-7. PubMed ID: 16391871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor.
    Petersen C; Petersen S; Milas L; Lang FF; Tofilon PJ
    Clin Cancer Res; 2000 Jun; 6(6):2513-20. PubMed ID: 10873107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celecoxib induced tumor cell radiosensitization by inhibiting radiation induced nuclear EGFR transport and DNA-repair: a COX-2 independent mechanism.
    Dittmann KH; Mayer C; Ohneseit PA; Raju U; Andratschke NH; Milas L; Rodemann HP
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):203-12. PubMed ID: 17996386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of selective and non-selective cyclooxygenase-2 inhibitor on the growth of colon cancer cells].
    Wang CH; Ouyang Q; Tang CW; Huang MH; Li X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 37(4):547-50. PubMed ID: 16909598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2 inhibitors demonstrate anti-proliferative effects in oesophageal cancer cells by prostaglandin E(2)-independent mechanisms.
    Deasy BM; O'Sullivan-Coyne G; O'Donovan TR; McKenna SL; O'Sullivan GC
    Cancer Lett; 2007 Oct; 256(2):246-58. PubMed ID: 17707579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific COX-2 inhibitor, meloxicam, suppresses proliferation and induces apoptosis in human HepG2 hepatocellular carcinoma cells.
    Li J; Chen X; Dong X; Xu Z; Jiang H; Sun X
    J Gastroenterol Hepatol; 2006 Dec; 21(12):1814-20. PubMed ID: 17074019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2.
    Pyo H; Choy H; Amorino GP; Kim JS; Cao Q; Hercules SK; DuBois RN
    Clin Cancer Res; 2001 Oct; 7(10):2998-3005. PubMed ID: 11595687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers.
    Xin B; Yokoyama Y; Shigeto T; Futagami M; Mizunuma H
    Cancer; 2007 Aug; 110(4):791-800. PubMed ID: 17582802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of ionizing radiation-induced G2 arrest by cyclooxygenase-2 and its inhibitor celecoxib.
    Jun HJ; Kim YM; Park SY; Park JS; Lee EJ; Choi SA; Pyo H
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):225-34. PubMed ID: 19695440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of cyclooxygenase-2 correlates with resistance to radiation in human prostate adenocarcinoma cells.
    Anai S; Tanaka M; Shiverick KT; Kim W; Takada S; Boehlein S; Goodison S; Mizokami A; Rosser CJ
    J Urol; 2007 May; 177(5):1913-7. PubMed ID: 17437847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction but not inhibition of COX-2 confers human lung cancer cell apoptosis by celecoxib.
    Ramer R; Walther U; Borchert P; Laufer S; Linnebacher M; Hinz B
    J Lipid Res; 2013 Nov; 54(11):3116-29. PubMed ID: 23943857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of poor survival by cyclooxygenase-2 in patients with T4 nasopharyngeal cancer treated by radiation therapy: clinical and in vitro studies.
    Chen WC; McBride WH; Chen SM; Lee KF; Hwang TZ; Jung SM; Shau H; Liao SK; Hong JH; Chen MF
    Head Neck; 2005 Jun; 27(6):503-12. PubMed ID: 15772955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of DNA repair as a mechanism of enhanced radioresponse of head and neck carcinoma cells by a selective cyclooxygenase-2 inhibitor, celecoxib.
    Raju U; Ariga H; Dittmann K; Nakata E; Ang KK; Milas L
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):520-8. PubMed ID: 16168844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells.
    Kern MA; Schubert D; Sahi D; Schöneweiss MM; Moll I; Haugg AM; Dienes HP; Breuhahn K; Schirmacher P
    Hepatology; 2002 Oct; 36(4 Pt 1):885-94. PubMed ID: 12297835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tumour effects by a trimodal combination of temozolomide, meloxicam and X-rays in cultures of human glioma cells.
    van Nifterik KA; Van Den Berg J; Slotman BJ; Van Rijn J
    Int J Radiat Biol; 2011 Feb; 87(2):192-201. PubMed ID: 21067299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of cyclooxygenase-2 suppresses the growth of pancreatic cancer cells in vitro and in vivo.
    Xu XF; Xie CG; Wang XP; Liu J; Yu YC; Hu HL; Guo CY
    Tohoku J Exp Med; 2008 Jun; 215(2):149-57. PubMed ID: 18577844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.